Skip to content
← Full study record

NCT00897910 · OUTCOME

Percentage of Myeloma-specific T Cells ex Vivo Expanded Using Flow Cytometry

Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma · Source last updated 2016-01-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Collection of PBMCs over a period of 9-12 months, and the laboratory component will be performed over another year.

Groups in this outcome

Collection of Blood and Bone Marrow.

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Collection of Blood and Bone Marrow.0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
groups
  1. id
    OG000
    title
    Collection of Blood and Bone Marrow.
reporting Status
POSTED
time Frame
Collection of PBMCs over a period of 9-12 months, and the laboratory component will be performed over another year.
title
Percentage of Myeloma-specific T Cells ex Vivo Expanded Using Flow Cytometry
type
PRIMARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice